vs
Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and Pineapple Financial Inc. (PAPL). Click either name above to swap in a different company.
Insight Molecular Diagnostics Inc. is the larger business by last-quarter revenue ($1.1M vs $707.3K, roughly 1.6× Pineapple Financial Inc.). Insight Molecular Diagnostics Inc. runs the higher net margin — -2015.4% vs -2756.2%, a 740.8% gap on every dollar of revenue. On growth, Pineapple Financial Inc. posted the faster year-over-year revenue change (-4.8% vs -23.4%). Pineapple Financial Inc. produced more free cash flow last quarter ($-3.3M vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs -2.0%).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
IMDX vs PAPL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1M | $707.3K |
| Net Profit | $-23.0M | $-19.5M |
| Gross Margin | 42.5% | 48.9% |
| Operating Margin | -2057.5% | -2518.8% |
| Net Margin | -2015.4% | -2756.2% |
| Revenue YoY | -23.4% | -4.8% |
| Net Profit YoY | 31.5% | -3174.1% |
| EPS (diluted) | $-0.75 | $-1.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $707.3K | ||
| Q4 25 | $1.1M | $721.7K | ||
| Q3 25 | $260.0K | $730.5K | ||
| Q2 25 | $518.0K | $746.9K | ||
| Q1 25 | $2.1M | $743.3K | ||
| Q4 24 | $1.5M | $766.1K | ||
| Q3 24 | $115.0K | $598.3K | ||
| Q2 24 | $104.0K | $736.4K |
| Q1 26 | — | $-19.5M | ||
| Q4 25 | $-23.0M | $-6.4M | ||
| Q3 25 | $-10.9M | $-1.8M | ||
| Q2 25 | $-9.7M | $-557.7K | ||
| Q1 25 | $-6.7M | $-595.4K | ||
| Q4 24 | $-33.5M | $-656.9K | ||
| Q3 24 | $-13.5M | $-1.7M | ||
| Q2 24 | $-4.5M | $-848.6K |
| Q1 26 | — | 48.9% | ||
| Q4 25 | 42.5% | 49.6% | ||
| Q3 25 | 53.5% | 27.8% | ||
| Q2 25 | 67.6% | 67.6% | ||
| Q1 25 | 62.0% | 43.4% | ||
| Q4 24 | 40.0% | 45.9% | ||
| Q3 24 | 43.5% | 43.2% | ||
| Q2 24 | 48.1% | 44.2% |
| Q1 26 | — | -2518.8% | ||
| Q4 25 | -2057.5% | -909.1% | ||
| Q3 25 | -4249.2% | -131.3% | ||
| Q2 25 | -1900.0% | -93.3% | ||
| Q1 25 | -318.0% | -80.6% | ||
| Q4 24 | -2262.9% | -90.5% | ||
| Q3 24 | -11752.2% | -232.8% | ||
| Q2 24 | -4453.8% | -121.7% |
| Q1 26 | — | -2756.2% | ||
| Q4 25 | -2015.4% | -891.6% | ||
| Q3 25 | -4174.6% | -250.3% | ||
| Q2 25 | -1880.7% | -74.7% | ||
| Q1 25 | -312.0% | -80.1% | ||
| Q4 24 | -2255.1% | -85.7% | ||
| Q3 24 | -11733.0% | -283.9% | ||
| Q2 24 | -4355.8% | -115.2% |
| Q1 26 | — | $-1.21 | ||
| Q4 25 | $-0.75 | $-4.79 | ||
| Q3 25 | $-0.34 | $-0.93 | ||
| Q2 25 | $-0.30 | $-0.05 | ||
| Q1 25 | $-0.26 | $-1.73 | ||
| Q4 24 | $-2.19 | $-2.60 | ||
| Q3 24 | $-0.98 | $-11.10 | ||
| Q2 24 | $-0.36 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-31.5M | $27.1M |
| Total Assets | $25.8M | $48.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.6M | — | ||
| Q3 25 | $18.7M | — | ||
| Q2 25 | $24.3M | — | ||
| Q1 25 | $31.0M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $9.3M | — |
| Q1 26 | — | $27.1M | ||
| Q4 25 | $-31.5M | $-5.5M | ||
| Q3 25 | $-9.2M | $906.7K | ||
| Q2 25 | $1.1M | $842.6K | ||
| Q1 25 | $10.2M | $739.7K | ||
| Q4 24 | $-12.3M | $1.3M | ||
| Q3 24 | $9.7M | $1.3M | ||
| Q2 24 | $22.7M | $2.0M |
| Q1 26 | — | $48.9M | ||
| Q4 25 | $25.8M | $10.6M | ||
| Q3 25 | $43.9M | $5.4M | ||
| Q2 25 | $50.5M | $4.7M | ||
| Q1 25 | $60.4M | $4.0M | ||
| Q4 24 | $35.1M | $4.1M | ||
| Q3 24 | $70.2M | $4.1M | ||
| Q2 24 | $74.7M | $4.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-3.3M |
| Free Cash FlowOCF − Capex | $-7.0M | $-3.3M |
| FCF MarginFCF / Revenue | -616.7% | -462.7% |
| Capex IntensityCapex / Revenue | 129.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-3.3M | ||
| Q4 25 | $-5.5M | $-489.7K | ||
| Q3 25 | $-4.5M | $-507.6K | ||
| Q2 25 | $-6.3M | $397.0K | ||
| Q1 25 | $-5.9M | $-172.6K | ||
| Q4 24 | $-5.4M | $-663.6K | ||
| Q3 24 | $-5.5M | $-264.7K | ||
| Q2 24 | $-6.0M | $123.0K |
| Q1 26 | — | $-3.3M | ||
| Q4 25 | $-7.0M | $-491.7K | ||
| Q3 25 | $-5.6M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-5.6M | — | ||
| Q3 24 | $-5.6M | $-264.7K | ||
| Q2 24 | $-6.2M | $122.7K |
| Q1 26 | — | -462.7% | ||
| Q4 25 | -616.7% | -68.1% | ||
| Q3 25 | -2135.4% | — | ||
| Q2 25 | -1279.5% | — | ||
| Q1 25 | -288.4% | — | ||
| Q4 24 | -374.5% | — | ||
| Q3 24 | -4884.3% | -44.2% | ||
| Q2 24 | -5931.7% | 16.7% |
| Q1 26 | — | 0.0% | ||
| Q4 25 | 129.9% | 0.3% | ||
| Q3 25 | 403.8% | — | ||
| Q2 25 | 67.4% | — | ||
| Q1 25 | 14.4% | — | ||
| Q4 24 | 14.4% | — | ||
| Q3 24 | 75.7% | 0.0% | ||
| Q2 24 | 183.7% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
